Diabetic Retinopathy Market Trends PowerPoint PPT Presentations

The global diabetic socks market size was USD 344.80 Million in 2021 and is expected to register a revenue CAGR of 4.8% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of diabetics and related complications such as Diabetic Food Ulcer (DFC) and diabetic neuropathy, growing consumer demand for better & improved accessibility and benefits offered by diabetic socks to patients over regular socks, and introduction of innovative smart sock technology are factors driving market revenue growth.

Market Size - $6.5 Billion in 2015, Market Growth - CAGR of 6.9%, Market Trends –Availability of better drug molecules for the treatment

Global proliferative diabetic retinopathy (pdr) market size is expected at 3.62 Bn by 2028 at a growth rate of 10.6% and growth analysis by The Business Research Company.

Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease. Read more details at: http://www.bigmarketresearch.com/global-diabetic-retinopathy-2015-2019-market

This report offers an analysis of the market based on product (reusable ophthalmic knives and single-use ophthalmic knives). The ophthalmic knives market research report further presents an in-depth insight on the growth prospects of the market across Asia, Europe, North America, and ROW. The report analyzes the market’s competitive landscape and offers information on several companies including Bausch Health, Diamatrix Ltd., HAI Laboratories, Inc., MANI, INC., Novartis AG, and Sidapharm.

This report offers an analysis of the market based on product (reusable ophthalmic knives and single-use ophthalmic knives). The ophthalmic knives market research report further presents an in-depth insight on the growth prospects of the market across Asia, Europe, North America, and ROW. The report analyzes the market’s competitive landscape and offers information on several companies including Bausch Health, Diamatrix Ltd., HAI Laboratories, Inc., MANI, INC., Novartis AG, and Sidapharm.

Diabetic Retinopathy Market Size By Type, By Management, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023

Get more information @ http://bit.ly/2kq4uSV Some of the key players in the diabetic retinopathy market include Bayer, Valeant Pharmaceutical, Novartis, F. Hoffmann-La Roche, Alimera Science, Abbott Laboratories, Pfizer, Regeneron Pharmaceutical, and Ampio Pharmaceuticals. Other notable players include Actavis, Boehringer Ingelheim, Kowa group, BCN peptides, ThromboGenics, Bausch & Lomb, iCo Therapeutics, Quark Pharmaceuticals and Vitreoretinal Technologies among others.

Download Sample Brochure @ http://bit.ly/2e9aeL8 DelveInsight’s Diabetic retinopathy - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and global market trends of the %Indication"% for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Diabetic retinopathy forecasted market share for ten years to 2020 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Diabetic retinopathy till 2020. Read Analysis @ http://bit.ly/2dRoh9m

Get more information @ http://bit.ly/2kq4uSV North America is predicted to contribute maximum revenue share in access of $4 billion by end of forecast timeframe. Growing access to anti-VEGF items like lucentis, eyelea and avastin along with growing consciousness for early diagnosis to avoid further blindness related with diabetes are the factors predicted to drive the industry demand in the region.

The research team projects that the Diabetic Retinopathy Treatment market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.

New Market Research Reports Title Optical Coherence Tomography Market " Has Been Added to Adroit Market Research into reports database.

Stay up-to-date with latest Insights of Ophthalmic Drugs Market research offered by Allied Market Research. Check how key trends and emerging drivers are shaping this industry growth. Get More Info@ https://www.alliedmarketresearch.com/ophthalmic-drugs-market

According to the latest research report by IMARC Group, The global ophthalmic devices market size reached US$ 27.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 38.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. More Info:- https://www.imarcgroup.com/ophthalmic-devices-market

Global retinal disorder treatment market size is expected at $16.42 Bn by 2027, at a growth rate of 9.1% and growth analysis by The Business Research Company.

Global Widefield Imaging Systems Market will exhibit a CAGR of around 7.35% for the forecast period of 2022-2028. Widefield imaging systems are used in diagnosing and detecting uveitis, diabetic retinopathy, retinal vascular tumours among others. Widefield imaging systems offer excellent postoperative documentation of retinal surgery. Widefield imaging systems is an imaging technology that relies on illumination with the resulting image being viewed and observed by an observer through the camera. The widefield imaging systems are rapidly being adopted by hospitals, clinics, and ambulatory surgery centres. Get Full Access of Report @ https://www.databridgemarketresearch.com/reports/global-widefield-imaging-systems-market

The global ophthalmic equipment market size was USD 60.49 Billion in 2021 and is expected to register a revenue CAGR of 5.0% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of glaucoma, cataracts, and other ocular conditions, increasing need for Research & Development (R&D) due to prevalence of eye-related diseases, need for improved patient outcomes, and use of cutting-edge technologies are major factors driving market revenue growth.

The ocular drug delivery market was valued at US$ 16,404.32 million in 2021 and is projected to reach US$ 27,016.20 million by 2028; it is expected to grow at a CAGR of 7.4 % from 2021 to 2028.

The major factors that drive the growth of the global ocular drug delivery technology market are the low bioavailability of drugs in conventional ocular therapies, increase in the incidence of glaucoma & macular degeneration, growing demand for targeted ocular drug delivery techniques, and increase in the number of approvals from government regulations for new ocular drug delivery techniques. Get sample copy of this report: https://goo.gl/S9nZMM

Diabetic macular edema treatment market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 3.65% in the above mentioned forecast period and would likely to reach an estimated value of 63.33 million by 2029 https://www.databridgemarketresearch.com/reports/global-diabetic-macular-edema-treatment-market

The global ophthalmic medical lasers market size is expected to grow from $1.04 billion in 2021 to $1.12 billion in 2022 at a compound annual growth rate (CAGR) of 7.6%.

The major competitors covered in the ophthalmic medical lasers market report are Alcon Laboratories Inc, Abbott Medical Optics Inc., Carl Zeiss Meditec AG. Read More @ http://bit.ly/3r49LPt

Major Players in the Ophthalmic Medical Lasers Market are Alcon Laboratories Inc, Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Topcon Corporation Read More @ https://bit.ly/2EdRAmH

Global Dermatitis Market by The Business Research Company is segmented as Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors https://bit.ly/3j2DKnH

Looking forward, the ophthalmic lasers market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/ophthalmic-lasers-market

Global proanthocyanidins market is set to witness a substantial CAGR of 6.25% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing demand for food products with anti- cancer properties and rising awareness about therapeutic benefits of dietary supplements are the factor for the growth of this market.

The prevalence of eye diseases such as glaucoma, cataracts, and so on is increasing significantly worldwide, as a consequence of increasing incidences of chronic disorders such as hypertension and diabetes. Due to changing lifestyle, the number of patients affected with diabetes and hypertension has increased considerably, thereby resulting in growth of ocular hypertension and diabetic retinopathy. The number of patients suffering from ophthalmic disorders is anticipated to increase in coming years and is in turn expected to accelerate the demand for ophthalmic devices.

Eye Health Ingredients Market size was worth over USD 180 million in 2016 and is set to exceed 1.8 kilo tons by 2024. Get more details @ https://goo.gl/77ZuWB

According to Goldstein Research, “Rising digitization is resulting in constant technological advancement in ophthalmology and optometry which plays an important role in the growth of ophthalmic diagnostic equipment market across the globe. However, lack of ophthalmologists and dearth of trained medical staffs for eye related disorders are obstructing the adoption of ophthalmic diagnostic equipments in hospitals and clinics.”

Get more information about the market: https://www.imarcgroup.com/vision-care-market According to IMARC Group’s latest report, titled “Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, the global vision care market reached a value of US$ 54 Billion in 2017. Request a sample report: https://www.imarcgroup.com/request?type=report&id=846&flag=B Browse more reports on Healthcare industry: http://www.imarcgroup.com/categories/healthcare-market-research-reports contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Follow us on twitter: @imarcglobal

Get more information about the market : http://www.imarcgroup.com/vision-care-market Good vision plays an important role in conducting different activities such as reading, writing, watching TV, etc. According to IMARC Group’s latest report, titled “Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the global vision care market reached a value of US$ 54 Billion in 2016. Request a sample report : http://www.imarcgroup.com/request?type=report&id=846&flag=B Browse more reports on Healthcare industry: http://www.imarcgroup.com/categories/healthcare-market-research-reports Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Follow us on twitter: @imarcglobal

Global Market Estimates is a market research and business consulting company who has proven track record in serving Fortune 500 companies.

The growth of the injectable drug delivery technologies market is primarily triggered by favorable reimbursement policies on injectable drugs and devices, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes in Europe, and improving patient compliance. See Full Report : http://bit.ly/1c4gocE

Medical Wide field Imaging Systems Market, by Component (Instruments, Software), Modality (Standalone, Portable), End-User (Specialty Clinics, Hospitals, Ambulatory Surgical Centers) – Global Revenue, Trends, Growth, Share, Size, and Forecast To 2022

Global Ophthalmology Drugs & Devices Market is expected to reach USD 36.95. billion by 2025, from USD 27.52 billion in 2017 growing at a CAGR of 4.3% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Diabetes mellitus is a group of metabolic diseases characterized by chronic hyperglycemia - high blood glucose levels - that results from defects in insulin secretion, insulin action, or a combination of these.

Global Market Estimates is a market research and business consulting company who has proven track record in serving Fortune 500 companies. Request for a sample copy of the Lutein Supplement Market report @: https://www.globalmarketestimates.com/lutein-supplement-market/

Global Market Estimates is a market research and business consulting company who has proven track record in serving Fortune 500 companies Request for a sample copy of the Lutein Vitamin Market report @: https://www.globalmarketestimates.com/lutein-vitamin-market/

The North America healthcare IT outsourcing market is expected to grow at a CAGR of 8.9% from 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Opthalmology PACS Market study added by Adroit Market Research will provide the budget of industry in 2020, also applications and growth predictions

The physiotherapy equipment market is estimated to grow at a CAGR of 6.8%to reach $19,786.3 million by 2019.Electric stimulation is the largest segment of the market. However, musculoskeletal will be the fastest-growing application segment during the forecast period. See Full Report @ bit.ly/1uVqa9w

The Global Retinal Disease Therapeutics Market is likely to expand at an impressive rate driven by recent government participation towards the prevention and control of retinal diseases

The study segments the diabetic retinopathy industry in light of major classification such as product type, potential markets, application, and end-user.

The study segments diabetic retinopathy industry in light of major classification such as product type, potential markets, application, and end-user.

Market Size – USD 7.39 billion in 2018, Market Growth – CAGR of 7.3%, Market Trends – Product Launches and Research for Advanced Tech Developments

The global ocular drug delivery market size valued at $67.7 billion in 2022, and is projected to reach $115.5 billion by 2032, growing at a CAGR of 5.5% from 2023 to 2032. The ocular drug delivery market growth is driven by advancement in ocular drug delivery technology, surge in ageing population, and rise in awareness about the various eye disorders. Aged population increases susceptibility to conditions such as age-related macular degeneration (AMD), cataracts, glaucoma, and diabetic retinopathy. Know More- https://www.alliedmarketresearch.com/ocular-drug-delivery-market

Globally, the ophthalmic devices market is witnessing significant growth due to increasing prevalence of eye disorders, such as diabetic retinopathy and macular degeneration. In addition, growing global aging population, increasing government initiatives towards healthcare infrastructure in developing countries, and increasing incidence of lifestyle-associated diseases are also driving the growth of the market.

The rising incidences of colorectal cancer, chronic pain, cardiovascular diseases and diabetic retinopathy and unwanted pregnancies globally are expected to drive the implantable drug delivery devices market.

In the field of US ophthalmology, laser surgery finds wide application in addressing various eye conditions, such as refractive errors (like LASIK and PRK), glaucoma (SLT), cataracts (laser cataract surgery), macular degeneration (laser treatment), diabetic retinopathy (laser photocoagulation), and retinal detachment (laser vitreolysis).

According to the latest study on “Vision Care Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product, and Distribution Channel,” the market was valued at US$ 66,934.51 million in 2019 and is projected to reach US$ 93,817.82 million by 2027; it is expected to grow at a CAGR of 4.5% during 2020–2027. The report highlights the trends prevailing in the global vision care market, and drivers and deterrents pertaining to the market growth.

Retinal Surgery Device Market will be US$ 2.87 Billion by 2027. Global Forecast, Impact of COVID-19, Industry Trends, by Product, Application, Growth, Opportunity Company Analysis.

The vascular endothelial growth factor (VEGF) inhibitor market size is expected to see strong growth in the next few years. It will grow to $13.98 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%.

Lutein Market Size, Industry Analysis Report, Regional Outlook, Application Development, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024

Vitrectomy serves as major treatment option that has gained popularity since the past few years and also offers retina correction for the entire field of the interior of the eye, which includes the peripheral vision. Moreover, when it comes to defining Vitrectomy, it is a surgical procedure employed to eradicate vitreous gel from the eye. This process is done when there is an occurrence of retinal detachment with vitreous haemorrhage. In addition, this procedure is used for eradication of scar tissue and treatment for small holes or tear in the macula.

Global eylea market size is expected to reach $10.16 Bn by 2028 at a rate of 5.5%, segmented as by product, prefilled syringe package, vial package

According to the latest research report by IMARC Group, The global eye health supplements market size is projected to exhibit a growth rate (CAGR) of 5.4% during 2024-2032. More Info:- https://www.imarcgroup.com/eye-health-supplements-market